search
Back to results

Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU

Primary Purpose

Pre-Eclampsia; Complicating Pregnancy, Pre-eclampsia Aggravated

Status
Not yet recruiting
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Glyceryl trinitrate vs phentolamine for prophylaxis against renal impairment
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pre-Eclampsia; Complicating Pregnancy

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: Severe preeclampsia defined by presentation of 2 or more of the following criteria: Blood pressure more than 160/100 Proteinuria Pitting edema With or without organ dysfunctions Exclusion Criteria: Patient relatives' refusal Recent active internal hemorrhage Chronic renal impairment or failure on dialysis for any other etiology

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    Group GTN

    Group Phentolamine

    Arm Description

    Glyceryl trinitrates (GTN) is infused to patients with severe hypertensive preeclampsia till oral anti-hypertensives and Magnesium sulfate loadings lower blood pressure

    Phentolamine is infused to patients with severe hypertensive preeclampsia till oral anti-hypertensives and Magnesium sulfate loadings lower blood pressure

    Outcomes

    Primary Outcome Measures

    kidney function tests
    creatinine in micromoles per liter and urea in millimole per liter

    Secondary Outcome Measures

    Full Information

    First Posted
    December 7, 2022
    Last Updated
    January 7, 2023
    Sponsor
    Assiut University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05687669
    Brief Title
    Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU
    Official Title
    Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    January 12, 2023 (Anticipated)
    Primary Completion Date
    April 12, 2023 (Anticipated)
    Study Completion Date
    June 12, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Assiut University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Severe pre-eclamptic toxemia has a high incidence of renal complications. Rapid diagnosis and termination of pregnancy are still the gold standard main treatment for pre-eclampsia. Rapid control of blood pressure showed to provide protection against many adverse effects of preeclampsia as intracranial hemorrhage, subcapsular hepatic hematoma and acute kidney injury (AKI). In Assiut university hospital ICU regimen, glyceryl trinitrate (GTN) was used primarily for this purpose. But it was accused in many cases as a cause for AKI without any other organ damage along with the severe preeclampsia disease. Some previous studies supported this assumption as , Ying-Hsuan .T. et.,al during their study of GTN on renal outcome during cardiopulmonary bypass in cardiac surgery. Phentolamine infusion is a new rising alternative for an old drug with a high safety profile. In this research protocol the researchers will study comparative effect of glyceryl trinitrate (GTN) versus phentolamine on renal outcome in severe pre-eclampsia patients during their stay in obstetric ICU.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pre-Eclampsia; Complicating Pregnancy, Pre-eclampsia Aggravated

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Model Description
    Prospective study will be done in Assiut university hospital obstetric ICU, 2 groups will be examined and randomly assigned: group A using glyceryl trinitrate (GTN) to emergency control of blood pressure and group B using phentolamine infusion to control blood pressure. Each group consists of 85patients:
    Masking
    Participant
    Masking Description
    Group(A): Glyceryl trinitrate (GTN) is labelled with "Drug A" on syringe pump. Group(B): Phentolamine is labelled with "Drug B" on syringe pump.
    Allocation
    Randomized
    Enrollment
    170 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Group GTN
    Arm Type
    Experimental
    Arm Description
    Glyceryl trinitrates (GTN) is infused to patients with severe hypertensive preeclampsia till oral anti-hypertensives and Magnesium sulfate loadings lower blood pressure
    Arm Title
    Group Phentolamine
    Arm Type
    Experimental
    Arm Description
    Phentolamine is infused to patients with severe hypertensive preeclampsia till oral anti-hypertensives and Magnesium sulfate loadings lower blood pressure
    Intervention Type
    Drug
    Intervention Name(s)
    Glyceryl trinitrate vs phentolamine for prophylaxis against renal impairment
    Intervention Description
    Glyceryl trinitrate vs phentolamine for prophylaxis against renal impairment
    Primary Outcome Measure Information:
    Title
    kidney function tests
    Description
    creatinine in micromoles per liter and urea in millimole per liter
    Time Frame
    96 hours after intervention

    10. Eligibility

    Sex
    Female
    Gender Based
    Yes
    Gender Eligibility Description
    only in preeclampsia patients which is complicating pregnancy in females
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Severe preeclampsia defined by presentation of 2 or more of the following criteria: Blood pressure more than 160/100 Proteinuria Pitting edema With or without organ dysfunctions Exclusion Criteria: Patient relatives' refusal Recent active internal hemorrhage Chronic renal impairment or failure on dialysis for any other etiology

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU

    We'll reach out to this number within 24 hrs